General Medicine and Primary Care

Host: Manesh R. Patel, MD

This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

Host: Daniel Gaudet, MD, PhD

This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

Host: Manesh R. Patel, MD

This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

Host: Marc P. Bonaca, MD, MPH

This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

Host: Christie Ballantyne, MD

This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.

Host: Kathleen Liu MD, PhD, FASN, BRCU

Guest: Professor Claudio Ronco

This episode dives into the recent advancements and best practices surrounding Extracorporeal Blood Purification within the complex scenario of multiorgan support. Join Drs. Kathleen Liu and Claudio Ronco as they engage in a thought-provoking discussion, exploring:

• Recent clinical trials suggesting minimal benefits of early CRRT in AKI for critically ill patients. The conversation delves into whether these findings translate to patients experiencing multiorgan failure, exploring the potential differentiating factors.
• The potential of CRRT to extend beyond renal support. The discussion explores how CRRT might offer support to other vital organs in the setting of multiorgan system failure.
• The role of current CRRT technology in eliminating inflammatory mediators. Dr. Ronco sheds light on the capabilities of current technology and its potential impact on the inflammatory response.

Join Dr. Liu and Dr. Ronco for an insightful exploration of extracorporeal blood purification’s evolving role in optimizing care for critically ill patients.

This episode is supported by an independent educational grant from Baxter.

Host: Kathleen Liu MD, PhD, FASN, BRCU

Guest: Jay L. Koyner, MD

In this episode of KDIGO Conversations in Nephrology, Dr. Kathleen Liu is joined by Dr. Jay Koyner to discuss the emerging field of persistent acute kidney injury (AKI). They delve into the question: what exactly is persistent AKI, and how does it differ from severe AKI? Dr. Liu and Dr. Koyner explore the key factors clinicians should consider when evaluating a patient's risk of developing persistent AKI. They also highlight the latest developments in this area of nephrology research, leaving listeners with valuable insights into the diagnosis and management of persistent AKI.

Join us as we discuss:

• What is persistent AKI, and how is it distinguished from severe AKI?
• What clinical factors should be considered when assessing a patient's risk of persistent AKI?
• What are some of the new developments in the field of persistent AKI research?
• How can this knowledge be applied to improve patient care?

This episode is supported by an independent educational grant from Baxter.

Host: Kathleen Liu MD, PhD, FASN, BRCU

Guest: Kianoush B. Kashani MD, MS, MSc, FASN, FCCP

In this episode, Dr. Kathleen Liu welcomes Dr. Kianoush Kashani to discuss the rising importance of personalized care in Acute Kidney Injury (AKI) treatment. They delve into the world of digital health, exploring how digital decision support tools can empower clinicians and improve patient outcomes.

This episode will address:

• Digital Health: Dr. Kashani breaks down the concept of digital health and its applications in the context of AKI management.
• The Power of Digital Tools: Discover how digital decision support systems can aid clinicians in early detection, risk stratification, and personalized treatment plans for AKI patients.
• Personalized Care for AKI: Dr. Liu and Dr. Kashani explore why a one-size-fits-all approach doesn't work for AKI, and how digital tools can pave the way for individualized care.
• Optimizing KRT Outcomes: Learn how digital health can improve decision-making around KRT, leading to better patient outcomes.

Tune in for this informative discussion on leveraging the power of digital health to personalize AKI care.

This episode is supported by an independent educational grant from Baxter.

Host: Marianna Fontana, MD

The HELIOS trials, a groundbreaking phase 3 program, are investigating the potential of vutrisiran, an RNA interference (RNAi) therapy, to combat both hereditary and wild-type ATTR amyloidosis. Building on a successful phase 1 study demonstrating vutrisiran's safety and effectiveness in reducing serum TTR, HELIOS is paving the way for a new era in ATTR treatment.

Join Dr. Marianna Fontana as she highlights the cardiac exploratory analysis of HELIOS-A and the design of HELIOS-B.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Derrick Barnes, MD

“Whatever dream you have of what you want your practice to look like, you can do.” That’s what OB-GYN Dr. Derrick Barnes believes when it comes to beginning a career in locum tenens. Tune in to hear Dr. Barnes share his experience with locum tenens work and how it offered him variety and flexibility in his career.